Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61

1.

ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's Disease.

Krela-Kaźmierczak I, Skrzypczak-Zielińska M, Kaczmarek-Ryś M, Michalak M, Szymczak-Tomczak A, Hryhorowicz ST, Szalata M, Łykowska-Szuber L, Eder P, Stawczyk-Eder K, Tomczak M, Słomski R, Dobrowolska A.

J Clin Med. 2019 Aug 24;8(9). pii: E1306. doi: 10.3390/jcm8091306.

2.

Genetic Predisposition for Osteoporosis and Fractures in Postmenopausal Women.

Mitek T, Nagraba Ł, Deszczyński J, Stolarczyk M, Kuchar E, Stolarczyk A.

Adv Exp Med Biol. 2019 Jul 16. doi: 10.1007/5584_2019_413. [Epub ahead of print]

PMID:
31309515
3.

COL1A1, CCDC170, and ESR1 single nucleotide polymorphisms associated with distal radius fracture in postmenopausal Mexican women.

Farias-Cisneros E, Hidalgo-Bravo A, Miranda-Duarte A, Casas-Ávila L, Rozental TD, Velázquez-Cruz R, Valdés-Flores M.

Climacteric. 2019 Jun 27:1-10. doi: 10.1080/13697137.2019.1627313. [Epub ahead of print]

PMID:
31246104
4.

Association of RMND1/CCDC170-ESR1 single nucleotide polymorphisms with hip fracture and osteoporosis in postmenopausal women.

Hidalgo-Bravo A, Parra-Torres AY, Casas-Avila L, Jimenez-Ortega RF, Ramírez-Salazar EG, Patiño N, Rivera-Paredez B, Salmerón J, Valdés-Flores M, Velázquez-Cruz R.

Climacteric. 2019 Feb;22(1):97-104. doi: 10.1080/13697137.2018.1538339. Epub 2019 Jan 2.

PMID:
30601066
5.

The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women.

Mondockova V, Adamkovicova M, Lukacova M, Grosskopf B, Babosova R, Galbavy D, Martiniakova M, Omelka R.

BMC Med Genet. 2018 Sep 21;19(1):174. doi: 10.1186/s12881-018-0684-8.

6.

Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study.

Trajanoska K, Morris JA, Oei L, Zheng HF, Evans DM, Kiel DP, Ohlsson C, Richards JB, Rivadeneira F; GEFOS/GENOMOS consortium and the 23andMe research team.

BMJ. 2018 Aug 29;362:k3225. doi: 10.1136/bmj.k3225.

7.

Effects of low-magnitude high-frequency vibration on osteoblasts are dependent on estrogen receptor α signaling and cytoskeletal remodeling.

Haffner-Luntzer M, Lackner I, Liedert A, Fischer V, Ignatius A.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):2678-2684. doi: 10.1016/j.bbrc.2018.08.023. Epub 2018 Aug 7.

PMID:
30093109
8.

Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects.

Medina-Gomez C, Kemp JP, Trajanoska K, Luan J, Chesi A, Ahluwalia TS, Mook-Kanamori DO, Ham A, Hartwig FP, Evans DS, Joro R, Nedeljkovic I, Zheng HF, Zhu K, Atalay M, Liu CT, Nethander M, Broer L, Porleifsson G, Mullin BH, Handelman SK, Nalls MA, Jessen LE, Heppe DHM, Richards JB, Wang C, Chawes B, Schraut KE, Amin N, Wareham N, Karasik D, Van der Velde N, Ikram MA, Zemel BS, Zhou Y, Carlsson CJ, Liu Y, McGuigan FE, Boer CG, Bønnelykke K, Ralston SH, Robbins JA, Walsh JP, Zillikens MC, Langenberg C, Li-Gao R, Williams FMK, Harris TB, Akesson K, Jackson RD, Sigurdsson G, den Heijer M, van der Eerden BCJ, van de Peppel J, Spector TD, Pennell C, Horta BL, Felix JF, Zhao JH, Wilson SG, de Mutsert R, Bisgaard H, Styrkársdóttir U, Jaddoe VW, Orwoll E, Lakka TA, Scott R, Grant SFA, Lorentzon M, van Duijn CM, Wilson JF, Stefansson K, Psaty BM, Kiel DP, Ohlsson C, Ntzani E, van Wijnen AJ, Forgetta V, Ghanbari M, Logan JG, Williams GR, Bassett JHD, Croucher PI, Evangelou E, Uitterlinden AG, Ackert-Bicknell CL, Tobias JH, Evans DM, Rivadeneira F.

Am J Hum Genet. 2018 Jan 4;102(1):88-102. doi: 10.1016/j.ajhg.2017.12.005.

9.

Genetic Polymorphisms in the ESR1 and VDR Genes Do Not Correlate With Osteoporosis in Patients With Familial Dysautonomia.

Cheishvili D, Maayan C, Sapozhnikov DM, Lax E, Dresner-Pollak R.

J Clin Densitom. 2018 Apr - Jun;21(2):205-212. doi: 10.1016/j.jocd.2017.01.002. Epub 2017 Feb 1.

PMID:
28161223
10.

ASCO 2016: highlights in breast cancer.

Bartsch R, Bergen E.

Memo. 2016;9(4):211-214. doi: 10.1007/s12254-016-0300-6. Epub 2016 Nov 30. Review.

11.

Genome-wide association meta-analyses identified 1q43 and 2q32.2 for hip Ward's triangle areal bone mineral density.

Pei YF, Hu WZ, Hai R, Wang XY, Ran S, Lin Y, Shen H, Tian Q; GEFOS-seq Consortium; AOGC Consortium; UK10K Consortium, Lei SF, Zhang YH, Papasian CJ, Deng HW, Zhang L.

Bone. 2016 Oct;91:1-10. doi: 10.1016/j.bone.2016.07.004. Epub 2016 Jul 7.

12.

Genome-wide association study using family-based cohorts identifies the WLS and CCDC170/ESR1 loci as associated with bone mineral density.

Mullin BH, Walsh JP, Zheng HF, Brown SJ, Surdulescu GL, Curtis C, Breen G, Dudbridge F, Richards JB, Spector TD, Wilson SG.

BMC Genomics. 2016 Feb 25;17:136. doi: 10.1186/s12864-016-2481-0.

13.

Estrogen receptor α (ESR1) IVS1-397T>C polymorphism lowers risk of fracture.

Wang J, Feng G, Li H, Li W, Pan Z, Wang J.

Int J Clin Exp Med. 2015 Aug 15;8(8):12696-705. eCollection 2015.

14.

Influence of vitamin D and estrogen receptor gene polymorphisms on calcium absorption: BsmI predicts a greater decrease during energy restriction.

Chang B, Schlussel Y, Sukumar D, Schneider SH, Shapses SA.

Bone. 2015 Dec;81:138-144. doi: 10.1016/j.bone.2015.07.011. Epub 2015 Jul 9.

15.

CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss.

Rodríguez-Sanz M, García-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, Díez-Pérez A, Grinberg D, Tusquets I, Nogués X.

J Mol Endocrinol. 2015 Aug;55(1):69-79. doi: 10.1530/JME-15-0079. Epub 2015 Jun 24.

PMID:
26108486
16.

Estrogen receptor alpha gene PvuII polymorphism and risk of fracture in postmenopausal women: a meta-analysis.

Deng W, Han JC, Chen L, Qi WL.

Genet Mol Res. 2015 Feb 13;14(1):1293-300. doi: 10.4238/2015.February.13.8.

17.

CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapy.

Masi L, Ottanelli S, Berni R, Cacudi E, Giusti F, Marcucci G, Cavalli L, Fossi C, Marini F, Ciuffi S, Tanini A, Brandi ML.

Clin Cases Miner Bone Metab. 2014 Jan;11(1):36-43.

18.

Association between estrogen receptor α gene (ESR1) PvuII (C/T) and XbaI (A/G) polymorphisms and hip fracture risk: evidence from a meta-analysis.

Tang L, Cheng GL, Xu ZH.

PLoS One. 2013 Dec 18;8(12):e82806. doi: 10.1371/journal.pone.0082806. eCollection 2013.

19.

Association of ESR1 and C6orf97 gene polymorphism with osteoporosis in postmenopausal women.

Luo L, Xia W, Nie M, Sun Y, Jiang Y, Zhao J, He S, Xu L.

Mol Biol Rep. 2014 May;41(5):3235-43. doi: 10.1007/s11033-014-3186-6. Epub 2014 Jan 31.

PMID:
24481879
20.

Estrogen Receptor Gene (ESR1) PVUII and XBAI Polymorphisms and Bone Mineral Density in Kazakh Women.

Akilzhanova A, Abilova Z, Aitkulova A, Zhumatova Z, Akilzhanova G, Zholdybayeva E, Momynaliev K.

Cent Asian J Glob Health. 2014 Jan 24;2(Suppl):100. doi: 10.5195/cajgh.2013.100. eCollection 2013.

Supplemental Content

Loading ...
Support Center